Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 5
Results: 38
It Can Wait.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 439, doi. 10.1002/onco.13773
- By:
- Publication type:
- Article
Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 406, doi. 10.1002/onco.13769
- By:
- Publication type:
- Article
Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e898, doi. 10.1002/onco.13768
- By:
- Publication type:
- Article
Intracranial Foreign Body Granuloma Mimicking Brain Tumor Recurrence: A Case Series.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e893, doi. 10.1002/onco.13766
- By:
- Publication type:
- Article
Remembering José.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 441, doi. 10.1002/onco.13764
- By:
- Publication type:
- Article
Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 364, doi. 10.1002/onco.13761
- By:
- Publication type:
- Article
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 422, doi. 10.1002/onco.13755
- By:
- Publication type:
- Article
Clinicopathologic and Genomic Characterization of PD‐L1 Positive Urothelial Carcinomas.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 375, doi. 10.1002/onco.13753
- By:
- Publication type:
- Article
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum‐Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 433, doi. 10.1002/onco.13752
- By:
- Publication type:
- Article
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e769, doi. 10.1002/onco.13744
- By:
- Publication type:
- Article
Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e827, doi. 10.1002/onco.13739
- By:
- Publication type:
- Article
Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e905, doi. 10.1002/onco.13736
- By:
- Publication type:
- Article
Adjuvant Treatment with 5‐Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 397, doi. 10.1002/onco.13727
- By:
- Publication type:
- Article
Administration Method of Adjuvant Tegafur‐Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e735, doi. 10.1002/onco.13724
- By:
- Publication type:
- Article
Real‐World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the U.S.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e817, doi. 10.1002/onco.13721
- By:
- Publication type:
- Article
Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e847, doi. 10.1002/onco.13720
- By:
- Publication type:
- Article
Cervical Cancer in Sub‐Saharan Africa: A Multinational Population‐Based Cohort Study of Care and Guideline Adherence.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e807, doi. 10.1002/onco.13718
- By:
- Publication type:
- Article
A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 356, doi. 10.1002/onco.13714
- By:
- Publication type:
- Article
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 389, doi. 10.1002/onco.13711
- By:
- Publication type:
- Article
Health‐Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta‐Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e794, doi. 10.1002/onco.13709
- By:
- Publication type:
- Article
Global Precision Oncology: A Call to Action on Expanding Access to Targeted Cancer Therapies.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 353, doi. 10.1002/onco.13708
- By:
- Publication type:
- Article
College of American Pathologists Tumor Regression Grading System for Long‐Term Outcome in Patients with Locally Advanced Rectal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e780, doi. 10.1002/onco.13707
- By:
- Publication type:
- Article
In Reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
In Regard to "A Phase Ib Study of NUC‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC‐08)".
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e902, doi. 10.1002/onco.13703
- By:
- Publication type:
- Article
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH‐Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e838, doi. 10.1002/onco.13701
- By:
- Publication type:
- Article
Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 427, doi. 10.1002/onco.13698
- By:
- Publication type:
- Article
Weekly Paclitaxel‐Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 366, doi. 10.1002/onco.13697
- By:
- Publication type:
- Article
Implementing Historical Controls in Oncology Trials.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e859, doi. 10.1002/onco.13696
- By:
- Publication type:
- Article
Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e756, doi. 10.1002/onco.13695
- By:
- Publication type:
- Article
Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 362, doi. 10.1002/onco.13689
- By:
- Publication type:
- Article
Impact of Obesity on Quality of Life, Psychological Distress, and Coping on Patients with Colon Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e874, doi. 10.1002/onco.13687
- By:
- Publication type:
- Article
Treatment Outcomes of Well‐Differentiated High‐Grade Neuroendocrine Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 383, doi. 10.1002/onco.13686
- By:
- Publication type:
- Article
Long‐Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow‐Up
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e749, doi. 10.1002/onco.13684
- By:
- Publication type:
- Article
Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e863, doi. 10.1002/onco.13629
- By:
- Publication type:
- Article
High‐Flow Oxygen and High‐Flow Air for Dyspnea in Hospitalized Patients with Cancer: A Pilot Crossover Randomized Clinical Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e883, doi. 10.1002/onco.13622
- By:
- Publication type:
- Article
A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Patients with Advanced Breast Cancer After First‐Line Chemotherapy.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e742, doi. 10.1002/onco.13614
- By:
- Publication type:
- Article
"Often Relatives are the Key [...]" –Family Involvement in Treatment Decision Making in Patients with Advanced Cancer Near the End of Life.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e831, doi. 10.1002/onco.13557
- By:
- Publication type:
- Article